Kernel is developing hardware and software for implantable devices for people with neurological and degenerative diseases like epilepsy, dementia and Alzheimer’s disease . Kernel plans to collect data from human clinical trials where patients have implantable devices . Kernel is researching how the brain carries out core functions. In the future, Kernel aims to use brain implants to augment human intelligence as a way of helping human intelligence co-evolve with artificial intelligence .
Kernel was founded by Bryan Johnson (CEO) in 2016 and is a team of neuroscientists and engineers . Johnson previously founded Braintree and sold it to PayPal in 2013. They have also brought on KRS CEO and founder, neuroengineer Christian Wentz . Theodore Berger of University of Southern California is acting chief science officer. Ed Boyden (MIT) is chief scientific advisor and Adam Marblestone (MIT) is chief strategy officer .
Kendall Research Systems
Kernel acquired Kendall Research Systems’ (KRS) clinical development program and their neural interface technologies in 2017.
On October 20, 2016 Kernal completed their series A funding round with $100 million from Bryan Johnson.
Chief Strategy Officer
Chief Scientific Advisor
Acting Chief Science Officer
Hi. I am Bryan Johnson.
Inside the Race to Hack the Human Brain
John H. Richardson
Documentaries, videos and podcasts
Rebooting The Brain | Bryan Johnson | Web Summit Keynote 2018
November 16, 2017
- NeuralinkNanobiotechnology company developing brain-machine interface to connect humans and computers based in San Francisco, California.
- OpenwaterOpenwater is a San Francisco company founded in 2016 that develops imaging technology for medical applications and brain-to-computer communications.
- Artificial intelligenceArtificial intelligence (AI) is intelligence exhibited by machines.